Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

Hyperparathyroidism in hereditary syndromes: special expressions and special managements.

Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N37-43. Review.

PMID:
12412776
2.

Genetic defects associated with familial and sporadic hyperparathyroidism.

Hendy GN, Cole DE.

Front Horm Res. 2013;41:149-65. doi: 10.1159/000345675. Epub 2013 Mar 19.

PMID:
23652676
3.

Molecular pathogenesis of primary hyperparathyroidism.

Cetani F, Pardi E, Borsari S, Marcocci C.

J Endocrinol Invest. 2011 Jul;34(7 Suppl):35-9. Review.

PMID:
21985978
4.

[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].

Frank-Raue K, Leidig-Bruckner G, Lorenz A, Rondot S, Haag C, Schulze E, Büchler M, Raue F.

Dtsch Med Wochenschr. 2011 Sep;136(38):1889-94. doi: 10.1055/s-0031-1286358. Epub 2011 Sep 13. German.

PMID:
21915802
5.

Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.

Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F, Cianferotti L, Viacava P, Miccoli P, Gasperi M, Pinchera A, Marcocci C.

Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64.

PMID:
11966738
6.

Parathyroid surgery in familial hyperparathyroid disorders.

Carling T, Udelsman R.

J Intern Med. 2005 Jan;257(1):27-37. Review.

7.

Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.

Watanabe T, Tsukamoto F, Shimizu T, Sugimoto T, Taguchi T, Nishisho I, Nakazawa H, Shiba E, Shishiba Y, Takai S.

Endocr J. 1998 Oct;45(5):637-46. Review.

PMID:
10395244
8.

Molecular pathogenesis of primary hyperparathyroidism.

Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N30-6. Review.

PMID:
12412775
9.

Molecular genetics of primary and secondary hyperparathyroidism.

Dotzenrath C, Goretzki PE, Farnebo F, Teh BT, Weber G, Röher HD, Larsson C.

Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:105-7. Review.

PMID:
8981014
10.

Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.

Frank-Raue K, Rondot S, Hoeppner W, Goretzki P, Raue F, Meng W.

J Clin Endocrinol Metab. 2005 Jul;90(7):4063-7. Epub 2005 May 3. Erratum in: J Clin Endocrinol Metab. 2005 Oct;90(10):5575.

PMID:
15870131
11.

Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).

Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV.

Hum Mutat. 2010 Jan;31(1):E1089-101. doi: 10.1002/humu.21170.

PMID:
19953642
12.

Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.

Uchino S, Noguchi S, Nagatomo M, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Wakiya S, Adachi M.

Biomed Pharmacother. 2000 Jun;54 Suppl 1:100s-103s.

PMID:
10915003
13.

Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors.

Willeke F, Hauer MP, Buchcik R, Gebert JF, Hahn M, Fitze G, Mechtersheimer G, Möller P, Saeger HD, Herfarth C, Schackert HK.

Surgery. 1998 Sep;124(3):484-90.

PMID:
9736899
14.

Hyperparathyroidism and multiple endocrine neoplasia.

Malone JP, Srivastava A, Khardori R.

Otolaryngol Clin North Am. 2004 Aug;37(4):715-36, viii. Review.

PMID:
15262511
15.

Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.

Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K.

Clin Endocrinol (Oxf). 2006 Jul;65(1):9-16.

PMID:
16817812
16.

Genetic alterations in primary and secondary hyperparathyroidism.

Shan L, Nakamura Y, Nakamura M, Yokoi T, Kakudo K.

Pathol Int. 1998 Aug;48(8):569-74. Review.

PMID:
9736402
17.

Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?

Skandarajah A, Barlier A, Morlet-Barlat N, Sebag F, Enjalbert A, Conte-Devolx B, Henry JF.

World J Surg. 2010 Jun;34(6):1294-8. doi: 10.1007/s00268-009-0388-5.

PMID:
20058152
18.

Multiple endocrine neoplasia.

Thakker RV.

Horm Res. 2001;56 Suppl 1:67-72. Review.

PMID:
11786689
19.

Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.

Cetani F, Pardi E, Ambrogini E, Lemmi M, Borsari S, Cianferotti L, Vignali E, Viacava P, Berti P, Mariotti S, Pinchera A, Marcocci C.

Clin Endocrinol (Oxf). 2006 Feb;64(2):146-52.

PMID:
16430712
20.

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

Dwight T, Twigg S, Delbridge L, Wong FK, Farnebo F, Richardson AL, Nelson A, Zedenius J, Philips J, Larsson C, Teh BT, Robinson B.

Clin Endocrinol (Oxf). 2000 Jul;53(1):85-92.

PMID:
10931084
Items per page

Supplemental Content

Write to the Help Desk